D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells
- 1 May 2013
- journal article
- research article
- Published by Elsevier BV in Journal of Dermatological Science
- Vol. 71 (1), 37-44
- https://doi.org/10.1016/j.jdermsci.2013.03.008
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 24 references indexed in Scilit:
- Animal Models of Atopic DermatitisJournal of Investigative Dermatology, 2009
- Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: Preventive and therapeutic effects on experimental autoimmune encephalomyelitisBiochemical and Biophysical Research Communications, 2008
- Neuropeptides activate human mast cell degranulation and chemokine productionImmunology, 2008
- D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+-T cellsJournal of Neuroimmunology, 2006
- Reduced cancer incidence among patients with schizophreniaCancer, 2005
- Strain difference of murine bone marrow-derived mast cell functionsJournal of Leukocyte Biology, 2005
- Close encounters of the monoamine kind: immune cells betray their nervous dispositionImmunology, 2005
- Immediate-Type Hypersensitivity Response Followed by a Late Reaction Is Induced by Repeated Epicutaneous application of Contact Sensitizing Agents in MiceJournal of Investigative Dermatology, 1995
- IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells.The Journal of Experimental Medicine, 1983
- LEVODOPA AND Ro 4-4602 IN PSORIASISThe Lancet, 1972